| # | Drug | Count |
|---|---|---|
| 0 | FLUOXETINE HYDROCHLORIDE | 6 |
| 1 | PAROXETINE HYDROCHLORIDE | 4 |
| 2 | ACETAMINOPHEN | 3 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 3 |
| 4 | IBUPFROFEN | 3 |
| 5 | IBUPROFEN | 3 |
| 6 | IBUPROFEN 200 MG | 3 |
| 7 | IBUPROFEN 200MG | 3 |
| 8 | IBUPROFEN CAPSULE | 3 |
| 9 | IBUPROFEN CAPSULES 200 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHYLERGONOVINE MALEATE | 2 | 0.0033 |
| 1 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 2 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | FAMCICLOVIR | 1 | 0.0004 |
| 4 | GABAPENTIN ENACARBIL | 1 | 0.0004 |
| 5 | NICARDIPINE | 1 | 0.0002 |
| 6 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | 2 | 0.0002 |
| 7 | ELOSULFASE ALFA | 1 | 0.0002 |
| 8 | BUROSUMAB | 1 | 0.0002 |
| 9 | LOPINAVIR AND RITONAVIR | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Barbiturate [EPC] | 2 | 0.0002 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Progesterone [EPC] | 1 | 0.0000 |
| 4 | Methylxanthine [EPC] | 2 | 0.0000 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Central Nervous System Stimulant [EPC] | 2 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |